Rheological properties of aqueous Pluronic-alginate systems containing liposomes

被引:53
作者
Grassi, G.
Crevatin, A.
Farra, R.
Guarnieri, G.
Pascotto, A.
Rehimers, B.
Lapasin, R.
Grassi, M.
机构
[1] Univ Trieste, DICAMP, Dept Chem Engn, I-34127 Trieste, Italy
[2] Univ Hosp Trieste, Dept Internal Med, I-34149 Trieste, Italy
[3] Civ Hosp, Cardiovasc Dept, I-30035 Venice, Italy
关键词
Pluronic; alginate; rheology; erosion;
D O I
10.1016/j.jcis.2006.04.068
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Rheological and erosion studies regarding a liposome-containing polymeric blend that is propaedeutic to its use in paving techniques in tubular organs, such as blood vessels, are reported. Attention is focused on an aqueous polymeric blend composed of Pluronic (PF127) and alginate (Protanal LF 10/60) because both polymers, when dissolved in water at a sufficiently high concentration, are subjected to different structural mechanisms, which are driven by temperature increase and addition of bivalent cations, respectively, and both result in marked viscoelastic and plastic properties. After proving the compatibility between PF127 and alginate, we show that the structural transition temperature of the blend, T-ST, can be property modulated. In particular, we found that TST for an aqueous solution of pure Pluronic 20% w/w is about 21 degrees C and that even slight reductions in polymer concentration result in considerable TST decrease. The addition of salts or alginate (provided as Na-alginate) provokes a substantial decrease of TST and thus the alginate concentration in the blend should not exceed 1% w/w. In addition, liposomes slow down the structural transition but do not substantially affect the rheological properties of the system in the final state at higher temperatures, thus showing that they can be added to the polymeric blend without significant effects. Finally, erosion tests show that after contact with a source of bivalent cations, the polymeric blend containing PF127 and alginate shows an erosion resistance neatly improved with respect to the simple structured Pluronic system having the same polymer concentration. As a whole, all these results constitute the basis for future potential applications of the considered polymeric blend in tubular organs such as blood vessels. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:282 / 290
页数:9
相关论文
共 24 条
  • [1] Liposomes dispersed within a thermosensitive gel: A new dosage form for ocular delivery of oligonucleotides
    Bochot, A
    Fattal, E
    Gulik, A
    Couarraze, G
    Couvreur, P
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (09) : 1364 - 1369
  • [2] A NONINVASIVE METHOD TO ESTIMATE WALL SHEAR RATE USING ULTRASOUND
    BRANDS, PJ
    HOEKS, APG
    HOFSTRA, L
    RENEMAN, RS
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 1995, 21 (02) : 171 - 185
  • [3] Draper NR., 1966, APPL REGRESSION ANAL
  • [4] Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids
    Fattal, E
    De Rosa, G
    Bochot, A
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 277 (1-2) : 25 - 30
  • [5] ALGINATES
    GACESA, P
    [J]. CARBOHYDRATE POLYMERS, 1988, 8 (03) : 161 - 182
  • [6] BIOLOGICAL INTERACTIONS BETWEEN POLYSACCHARIDES AND DIVALENT CATIONS - EGG-BOX MODEL
    GRANT, GT
    MORRIS, ER
    REES, DA
    SMITH, PJC
    THOM, D
    [J]. FEBS LETTERS, 1973, 32 (01) : 195 - 198
  • [7] Hammerhead ribozymes targeted against cyclin E and E2F1 cooperate to down-regulate coronary smooth muscle cell proliferation
    Grassi, G
    Schneider, A
    Engel, S
    Racchi, G
    Kandolf, R
    Kuhn, A
    [J]. JOURNAL OF GENE MEDICINE, 2005, 7 (09) : 1223 - 1234
  • [8] Selection and characterization of active hammerhead ribozymes targeted against cyclin E and E2F1 full-length mRNA
    Grassi, G
    Grassi, M
    Platz, J
    Bauriedel, G
    Kandolf, R
    Kuhn, A
    [J]. ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2001, 11 (05): : 271 - 287
  • [9] Grassi G., 2005, AM J DRUG DELIVERY, V3, P239, DOI [10.2165/00137696-200503040-00004, DOI 10.2165/00137696-200503040-00004]
  • [10] Guyton A.C., 2005, HAEMOLYTIC ANOEMIA M, V10th, P388